戻る / Previous page

  • Featured
  • Special Price

Burger's Medicinal Chemistry, Drug Discovery and Development, 7 REV UPD Edition
バーガー メディシナルケミストリー、薬の発見と発展 8巻セット 第7版

Burger's Medicinal Chemistry, Drug Discovery and Development, 7 REV UPD Edition バーガー メディシナルケミストリー、薬の発見と発展 8巻セット 第7版
Author
Abraham, Donald J. (EDT)/ Rotella, David P. (EDT) 
Publisher
Wiley 
Publication Date
Oct, 2010 
ISBN
0470278153 or 9780470278154
HARDCOVER 
6,880 Pages
出版済み 3-5週間でお届けいたします。
The delivery time takes 3 to 5 weeks

¥ 326,820 (tax included)

Description

Now in its seventh edition, Burger's Medicinal Chemistry, Drug Discovery and Development provides an established, recognized, authoritative and comprehensive source on medicinal chemistry and drug discovery and development. This flagship reference for medicinal chemists and pharmaceutical professions has been thoroughly updated and expanded across 8 volumes to incorporate the entire process of drug development (preclinical testing, clinical trials, etc.) alongside the traditional strengths in medicinal chemistry and drug discovery.

Contents

Vol 1: Methods in Drug Discovery.
History of Quantitative Structure Activity Relationships.
Mass spectrometry and drug discovery.
Chirality and Biological Activity.
Analog design.
SNPs: Single Nucleotide Polymorphisms and Pharmacogenomics - individually designed drug therapy.
Design of peptidomimetics.
Dual Acting Drugs.
Combinational chemistry and multiple parallel synthesis.
Allosteric proteins and drug discovery.
Principles of drug metabolism.
Pharmacophore-based drug design.
Use of biological fingerprints vs Structure/chemotypes to describe molecules.
Recent advances in development, validation and exploitation of QSAR models .
The Application of recombinant DNA Technology in medicinal chemistry and drug discovery.
Structural genomics, its application in Chemistry, Biology, Medicine, and Drug Discovery.

Vol 2: Discovering Lead Molecules.
Virtual screening.
Utility and applications of in vitro ADMET profiling in lead discovery.
Retrometabolism-Based Drug Design and Targeting.
Natural product screening.
Microbes to man; from the depths to drugs.
Multi-objective Optimization For Drug Discovery.
GPCR homology model development and applications.
Structural Alerts for Toxicity.
Protein - Protein Interactions as Drug Discovery Targets.
NMR-based Screening and Drug Discovery.
Membrane transport proteins and drug transport.
Receptor targets in drug discovery and development.
Selective Toxicities.
Chemogenomics - Systematization of Drug Discovery.
Docking and Scoring in Drug Discovery.
Recent Trends in Structure-Based Drug Design and Energetics.
QM and QM/MM Approaches to Evaluating Binding Affinities.
Assessing the Bioavailability of Drug Delivery Systems: Mathematical Modeling.
Protein flexibility in in silico screening.

Vol 3: Drug Development.
Large scale and scale up synthesis.
Physicochemical characterization and principles of oral dosage form selection.
The FDA and drug regulatory issues.
Intellectual property in drug discovery and biotechnology.
Polymorphism and conjugation in drug delivery (crystal engineering).
Prodrugs: Strategic Deployment, Metabolic Considerations and Chemical Design Principles.
Process Development of Protein Therapeutics.
Cost-Effectiveness Analyses throughout the Drug Development Life Cycle.
Provisional BCS Classification of the Leading Oral Drugs on the Global Market.
The role of permeability in drug ADME/PK, interactions and toxicity, and the Permeability-based Classification System (PCS).
Salt screening and selection.
Enzymatic assays for HTS or Assay Development for HTS.
Crystallographic Survey of the Endogenous Albumin Drug Transport System and its Application in Cancer Chemotherapy.
Nanotechnology in pharmaceuticals.

Vol 4: Cardiovascular, Endocrine and Metabolic Diseases.
Diabetes Drugs and Emerging Targets.
DPP-4 inhibitors.
Nuclear hormone receptor medicinal chemistry.
Thyroid hormones and thyromimetics.
Antihypertensives:renin inhibitors.
Antihypertensives - Angiotensin-converting enzyme inhibitors.
Atherosclerosis I: LDL Cholesterol Lowering.
Atherosclerosis I: HDL Elevation.
Anticoagulants.
Antiplatelets.
Congestive Heart Failure.
Endogenous vasoactive peptides.
Hematopoietic agents.
Oxygen delivery via allosteric effectors of hemoglobin and blood substitutes.

Vol 5: Pulmonary, Bone, Immunology, Vitamins and Autocoid Therapeutic Agents.
Fundamentals of steroid chemistry and biochemistry.
Antiinflammatory Glucocorticoids.
Male sex hormones, analogs, and antagonists.
Female Sex Hormones (pick up from the online).
Medicinal chemistry and therapeutic applications of the gaseotransmitters NO, CO and H2S and their prodrugs.
Retinoids.
Multiple sclerosis.
Ophthalmic agents.
Vitamins.
Drug Discovery in Non-Life Threatening Disorders: Erectile Dysfunction, Insomnia and Smoking Cessation.
Osteoporosis therapy: mechanistic antiresoptives.
Osteoporosis therapy: anabolics.
Current and Emerging Therapies in Chronic Obstructive Pulmonary Disease.
Agents acting on prostanoid & TX receptors.
Therapeutic agents acting on RNA.
Immunosuppressive agents for the prevention of transplantation rejection.

Vol 6: Cancer.
Natural product cytotoxics.
Histone Deacetylase Inhibitors: A brief overview of their role and medicinal chemistry.
Synthetic DNA-targeted chemotherapeutic agents and related tumor-activated prodrugs.
PARP Inhibitors as Anticancer Agents.
Proteasome inhibitors.
CNS Cancers.
Kinase inhibitors: Approved Drugs and Clinical Candidates.
Structure-Based Design of Kinase Inhibitors: Molecular Recognition of Protein Multiple Conformations.
Cancer drug resistance-targets and therapies.
HSP inhibitors.
Gene therapy with plasmid DNA.

Vol 7: Antiinfectives.
The FDA Approved HIV-1 Protease Inhibitors for Treatment of HIV/AIDS.
HIV integrase.
CCR5 Antagonists.
Reverse Transcriptase Inhibitors (RTIs).
Anti HCV agents.
Anti-DNA Virus Agents.
B-lactam antibiotics-include monobactams, b-lactamase inhibitors.
Tetracyclines, aminoglycoside, macrolide, and miscellaneous antibiotics.
Synthetic antibacterial agents.
Antiprotozoal/ Antiparasitic Agents.
Antimalarials.
Anti-tuberculosis.

Vol 8: CNS Disorders.
Chemical Perspective on Neurotransmission and Drug Discovery for the Central Nervous System.
Cognition.
Cholinergics/anticholinergics/muscarinics/nicotinics.
CNS stimulants.
Anticonvulsants.
Antipsychotic agents.
Antidepressants.
Therapeutic Agents for the Treatment of Migraine.
Approaches to Amyloid Therapies for the Treatment of Alzheimers Disease .
Non-Amyloid Approaches to Alzheimer's Disease.
Stroke.
Therapeutic and Diagnostic Agents for Parkinson?s Disease.
Opioid Receptor Ligands.
PET and SPECT in Drug Development.

送料無料にてお届け

ご注文商品は海外からのお取り寄せのため,納期は3~5週間程頂きます。入荷の遅延,出版延期など納期に遅れが見込まれる場合はメールにてお知らせ致します

公費/校費/社費でのお支払い

ご注文の際,お支払方法を選択して頂く画面が表示されますので,「公費/校費/社費」をお選び頂き必要書類をご指定下さい。公費/校費/社費の場合でも、HP掲載価格で承ります。

書籍が見つからない場合

お問い合わせメールより書籍のタイトルや ISBNなど、お手持ちの情報をお知らせ下さい。お見積り、ご注文を承ります。

SSL グローバルサインのサイトシール